Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Juiz de Fora
Clinical trial register · Brazil

Clinical Trials in Juiz de Fora, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Brazil and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2233 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2233
Studies in scope
all four open statuses
1129
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
São Paulo 1203 Porto Alegre 891 Rio de Janeiro 472 Curitiba 432 Salvador 347

Trials with a site in Juiz de Fora

57 of 2233 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Brazil
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Juiz de Fora, Porto Alegre - RS, Salvador, São Paulo, Valinhos
2026-12-14
Recruiting
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
NCT07918040Hematologic Test, Agranulocytosis, Side Effects, Blood Pressure Monitoring
Matheus Furtado de Carvalho
Phase 4
50
Juiz de Fora
2026-11-13
Recruiting
Hoffmann-La Roche
Phase 2
120
Juiz de Fora
2026-06-03
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Botucatu, Brasília, Curitiba, Jaú, Juiz de Fora, Macaé, Natal, Niterói
2026-05-22
Recruiting
Boehringer Ingelheim
Phase 2
405
Curitiba, Juiz de Fora, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Valinhos
2026-04-20
Not yet open
Federal University of Juiz de Fora
Not applicable
102
Juiz de Fora
2026-04-15
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Goiânia, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, São José do Rio Preto, São Paulo, Vitória
2026-03-05
Recruiting
Daiichi Sankyo
Observational
2,120
Belo Horizonte, Blumenau, Caixias Do Sul, Campina Grande do Sul, Curitiba, Joinville, Juiz de Fora, Maringá
2026-03-03
Recruiting
AstraZeneca
Phase 2
320
Juiz de Fora, Pelotas, Porto Alegre, Salvador, São Paulo
2025-12-15
Recruiting
Hoffmann-La Roche
Phase 2
160
Brasília, Cuiab, Juiz de Fora, Curitiba, Porto Alegre, Ribeirão Preto, So Paulo
2025-12-05
Recruiting
Eli Lilly and Company
Phase 2
252
Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Maceió, Porto Alegre, São José dos Campos
2025-11-10
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Belo Horizonte, Botucatu, Brasília, Curitiba, Fortaleza, Jaú, Juiz de Fora, Macaé
2025-10-03
Recruiting
Sanofi
Phase 3
980
Juiz de Fora, Caxias do Sul, Porto Alegre, São José do Rio Preto, Barretos, Campinas, Aracaju, Brasília
2025-10-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2
315
Juiz de Fora, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
2025-09-26
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Salvador, Juiz de Fora, Curitiba, João Pessoa, Porto Alegre, Botucatu, Campinas, Ribeirão Preto
2025-09-22
Recruiting
AbbVie
Phase 3
120
Juiz de Fora, Curitiba, São Paulo
2025-07-28
Recruiting
Eli Lilly and Company
Phase 3
350
Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto
2025-06-26
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Brasília, Goiânia, Juiz de Fora, Teresina, Caxias do Sul, Passo Fundo, Porto Alegre, Barretos
2025-05-27
Recruiting
Biogen
Phase 3
454
Belo Horizonte, Juiz de Fora, Caxias do Sul, Porto Alegre, São Paulo
2025-05-08
Recruiting
AstraZeneca
Phase 3
11,300
Belém, Blumenau, Bragança Paulista, Brasília, Campina Grande do Sul, Campinas, Curitiba, Juiz de Fora
2025-03-14
Active, closed
Takeda
Phase 3
601
Juiz de Fora, Uberlândia, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2025-03-10
Recruiting
GlaxoSmithKline
Phase 3
440
São José do Rio Preto, Barra Mansa, Juiz de Fora, Porto Alegre, São Paulo
2024-09-11
Recruiting
GlaxoSmithKline
Phase 1
142
Porto Alegre, Juiz de Fora, Salvador
2024-09-02
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Aracaju, Belo Horizonte, Brasília, Fortaleza, Goiânia, Ijuí, Joinville, Juiz de Fora
2024-08-30
Active, closed
AbbVie
Phase 3
111
Juiz de Fora, Curitiba, Porto Alegre, São Paulo
2024-08-08
Active, closed
GlaxoSmithKline
Phase 4
302
Belo Horizonte, São José do Rio Preto, Cuiabá, Juiz de Fora, Passo Fundo, Porto Alegre, Salvador, São Paulo
2024-06-06
Recruiting
Takeda
Phase 2
268
Brasília, Juiz de Fora, Porto Alegre, Botucatu, Campinas, Jaú, Ribeirão Preto, Santos
2024-03-05
By invitation
Application of Social Media as a Supporting Tool in the Teaching and Learning Process of Dentistry Students
NCT07184359Social Media, Dental Education and Teaching Learning Processes
Karina Lopes Devito
Not applicable
90
Juiz de Fora
2024-01-14
Active, closed
AbbVie
Phase 3
289
Brasília, Juiz de Fora, Porto Alegre, Botucatu, Ribeirão Preto, São Paulo
2023-11-15
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Vitória, Salvador, Juiz de Fora, Ribeirão Preto, São Paulo
2023-10-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Brasília, Juiz de Fora, Porto Alegre, Santo André, São José do Rio Preto
2023-10-25
By invitation
Biogen
Phase 3
306
Salvador, Brasília, Santo Ângelo, Juiz de Fora, Porto Alegre, São Paulo, Rio de Janeiro
2023-10-03
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Belo Horizonte, Curitiba, Juiz de Fora, Porto Alegre, Salvador, São Paulo
2023-09-13
Active, closed
Bristol-Myers Squibb
Phase 3
774
Vitória, Belo Horizonte, Juiz de Fora, Porto Alegre, São Paulo, Uberlândia
2023-09-11
Active, closed
AbbVie
Phase 3
1,014
Vitória, Salvador, Juiz de Fora, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2023-07-25
Active, closed
Novartis Pharmaceuticals
Phase 4
240
Juiz de Fora, Porto Alegre, Barretos
2023-03-28
Active, closed
Bristol-Myers Squibb
Phase 3
516
Salvador, Lago Sul, Belo Horizonte, Juiz de Fora, Curitiba, Porto Alegre, Campinas, Ribeirão Preto
2023-01-12
Active, closed
Viatris Innovation GmbH
Phase 3
470
Belo Horizonte, Juiz de Fora, Passo Fundo, Porto Alegre, Rio de Janeiro, Salvador, Santa Cecília, São Bernardo do Campo
2022-12-13
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
381
Belo Horizonte, Cuiabá, Graça, Juiz de Fora, Moinhos de Vento, São José, São Paulo
2022-09-16
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Botucatu, Brasília, Campinas, Curitiba, Jaú, Juiz de Fora, Porto Alegre, Salvador
2022-09-13
Active, closed
Biogen
Phase 2/3
450
Fortaleza, Vitória, Salvador, Brasília, Santo Ângelo, Belo Horizonte, Juiz de Fora, Rio de Janeiro
2022-09-13
Active, closed
Novartis Pharmaceuticals
Phase 3
452
Vitória, Salvador, Belo Horizonte, Juiz de Fora, Recife, Porto Alegre, Santo André
2022-07-14
By invitation
Biogen
Phase 3
864
Fortaleza, Vitória, Salvador, Brasília, Santo Ângelo, Belo Horizonte, Juiz de Fora, Curitiba
2022-06-10
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 2/3
522
Aracaju, Belo Horizonte, Botucatu, Campinas, Curitiba, Fortaleza, Goiânia, Juiz de Fora
2022-03-30
Active, closed
Hoffmann-La Roche
Phase 3
303
Salvador, Belo Horizonte, Juiz de Fora, Curtiba, Ribeirão Preto, São Bernardo do Campo
2021-10-26
Active, closed
Beeline Medicines Corporation
Phase 2
248
Salvador, Cuiabá, Juiz de Fora, Curitiba, Porto Alegre, São Bernardo do Campo, São José do Rio Preto, São Paulo
2021-10-11
Active, closed
Bristol-Myers Squibb
Phase 3
670
Vitória, Salvador, Juiz de Fora, Curitiba, Porto Alegre, Santo André
2021-07-13
Active, closed
Oswaldo Cruz Foundation
Phase 3
556
Manaus, Juiz de Fora, Belém, Rio de Janeiro
2021-05-27
Active, closed
Biogen
Phase 3
548
Fortaleza, Vitória, Salvador, Brasília, Cuiabá, Belo Horizonte, Juiz de Fora, Curitiba
2021-05-25
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
Novartis Pharmaceuticals
Phase 4
1,000
Vitória, Salvador, Juiz de Fora, São José do Rio Preto, São Paulo, Rio de Janeiro
2020-12-22
Active, closed
AbbVie
Phase 3
56
Salvador, Juiz de Fora, Curitiba, Porto Alegre, São Paulo
2020-02-04
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Brasília, Campinas, Curitiba, Juiz de Fora, Passo Fundo, Porto Alegre, Rio de Janeiro, Salvador
2019-09-26
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Blumenau, Botucatu, Brasília, Campinas, Curitiba, Goiânia, Jaú, Juiz de Fora
2018-04-13
Rows per page Showing 1–57 of 57
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Brazilian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-brazil/city/juiz-de-fora

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Brazil and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,233 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 57 of those studies with a site in Juiz de Fora.

How many clinical trials are recruiting in Juiz de Fora?

26 of the 57 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 26 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Juiz de Fora), 57 studies
PhaseStudiesRecruitingShare
Phase 3331257.9%
Phase 210817.5%
Phase 2/36210.5%
Phase 4427%
Not applicable203.5%
Observational111.8%
Phase 1111.8%

Most active sponsors

Lead sponsors with the most studies (Juiz de Fora)
Lead sponsorStudiesRecruiting
AbbVie72
Janssen Research & Development, LLC63
Biogen51
Bristol-Myers Squibb41
GlaxoSmithKline43
Novartis Pharmaceuticals41
AstraZeneca33
Eli Lilly and Company33
Hoffmann-La Roche32
Boehringer Ingelheim21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.